Profile
Olivier Belamy is currently the Director-Industrialization at Affluent Medical SA since 2023.
Prior to this, he worked as the Chief Operating Officer at eCential Robotics SAS.
Olivier Belamy active positions
Companies | Position | Start |
---|---|---|
AFFLUENT MEDICAL | Corporate Officer/Principal | 2023-01-15 |
Former positions of Olivier Belamy
Companies | Position | End |
---|---|---|
eCential Robotics SAS
eCential Robotics SAS Medical SpecialtiesHealth Technology eCential Robotics SAS is a French Grenoble-based company that specializes in surgical robotics. The company develops and markets a unique system that unifies 2D/3D robotic imaging and real-time navigation. With 80 patents and seven trademarks, it offers orthopedic and neurosurgeons cutting-edge technology to visualize their operations, particularly minimally invasive surgery. The eCential Robotics platform is a universal system open to all implants. The company designs and produces all its equipment in Grenoble, FR, including hardware and software. The company was founded in 2009 by Stéphane Lavallée and Markus Fleute. | Chief Operating Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
AFFLUENT MEDICAL | Health Technology |
Private companies | 1 |
---|---|
eCential Robotics SAS
eCential Robotics SAS Medical SpecialtiesHealth Technology eCential Robotics SAS is a French Grenoble-based company that specializes in surgical robotics. The company develops and markets a unique system that unifies 2D/3D robotic imaging and real-time navigation. With 80 patents and seven trademarks, it offers orthopedic and neurosurgeons cutting-edge technology to visualize their operations, particularly minimally invasive surgery. The eCential Robotics platform is a universal system open to all implants. The company designs and produces all its equipment in Grenoble, FR, including hardware and software. The company was founded in 2009 by Stéphane Lavallée and Markus Fleute. | Health Technology |
- Stock Market
- Insiders
- Olivier Belamy